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Abstract
Beckwith-Wiedemann syndrome (BWS) is a fetal overgrowth and human imprinting disorder resulting from the deregulation
of a number of genes, including IGF2 and CDKN1C, in the imprinted gene cluster on chromosome 11p15.5. Most cases are
sporadic and result from epimutations at either of the two 11p15.5 imprinting centres (IC1 and IC2). However, rare familial
cases may be associated with germline 11p15.5 deletions causing abnormal imprinting in cis. We report a family with BWS
and an IC2 epimutation in which affected siblings had inherited different parental 11p15.5 alleles excluding an in cis
mechanism. Using a positional-candidate gene approach, we found that the mother was homozygous for a frameshift
mutation in exon 6 of NLRP2. While germline mutations in NLRP7 have previously been associated with familial hydatidiform
mole, this is the first description of NLRP2 mutation in human disease and the first report of a trans mechanism for
disordered imprinting in BWS. These observations are consistent with the hypothesis that NLRP2 has a previously
unrecognised role in establishing or maintaining genomic imprinting in humans.
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Introduction
Genomic imprinting is an epigenetic modification that causes
genes to be expressed according to their parent of origin. Although
less than 100 imprinted genes have been identified in human and
mice, many imprinted genes appear to have a critical role in
prenatal growth and development [1]. Molecular genetic analysis
of rare human imprinting disorders has played a critical role in
elucidating the mechanisms of genomic imprinting. In particular,
studies of the imprinting disorder Beckwith-Wiedemann syndrome
(BWS MIM 130650) have provided important insights into the
structure and function of imprinting centres [2]. BWS is a
congenital overgrowth syndrome, characterised by prenatal and
postnatal overgrowth, macroglossia and anterior abdominal wall
defects. Additionally, variable features include organomegaly,
neonatal hypoglycaemia, hemihypertrophy, urogenital abnormal-
ities and in about 5% of children, embryonal tumours (most
frequently Wilms’ tumour). The genetics of BWS are complex, but
involve mutation or altered expression of several closely linked
genes associated with cell cycle and growth control in the
imprinted 11p15.5 chromosomal region. Imprinted genes most
frequently implicated in the aetiology of BWS include the
paternally expressed IGF2, KCNQ1OT1 (LIT1) genes and the
maternally expressed H19 and CDKN1C (P57KIP2) genes.
KCNQ1OT1 and H19 transcripts are not translated but the IGF2
gene product is an important prenatal growth factor and the
CDKN1C protein is a candidate tumour suppressor that
negatively regulates the cell cycle [3]. The majority of BWS cases
are sporadic and result from epimutations of the distal (IC1) or
proximal (IC2) 11p15.5 imprinting centres (see [4] and references
within). IC1 is a differentially methylated region (DMR) about 5kb
upstream of H19 that has an ‘‘insulator function’’ regulated by the
zinc finger transcription factor, CTCF. The insulator is methyl-
ation sensitive, such that when CTCF binds to the unmethylated
maternal allele, the IGF2 promoters do not have access to (are
insulated from) enhancers downstream of H19. Methylation on the
paternal allele prevents CTCF from binding, thus permitting
interaction between the IGF2 promoters and the enhancers [5].
About 5–10% of sporadic BWS cases have hypermethylation of
the H19 DMR and in these cases IGF2 shows loss of imprinting
(LOI) and biallelic expression [6]. The second imprinting centre,
IC2 is a DMR located in intron 10 of the KCNQ1 gene and is
known as KvDMR1. The unmethylated paternal allele permits
transcription of the antisense transcript KCNQ1OT1 (also known as
LIT1) and silencing of genes including KCNQ1 and CDKN1C.
Maternal methylation at the KvDMR1 is thought to prevent
transcription of the KCNQ1OT1 gene and enable expression of
CDKN1C. Loss of methylation (LOM) at the KvDMR1 is seen in
up to 50% of sporadic BWS and is associated with biallelic
expression (loss of imprinting) of KCNQ1OT1 and silencing of
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maternal CDKN1C expression [7–9]. Apparent hypomethylation of
IC2 may, in rare cases, result from a germline IC2 deletion [10].
However, most BWS patients with IC2 methylation defects appear
to have an epimutation of unknown cause (although there is an
increased risk of BWS with IC2 epimutation in children conceived
by assisted reproductive technologies) [11–13]. In order to gain
insights into the factors responsible for IC2 imprinting defects, we
studied a family with BWS that displayed evidence of IC2
epimutations through a trans mechanism.
Materials and Methods
Ethics Statement
This study was conducted according to the principles expressed in
the Declaration of Helsinki. The study was approved by the South
Birmingham Research Ethics Committee (equivalent to the
Institutional Review Board of Birmingham Women’s Hospital)
reference number CA/5175. All patients provided written informed
consent for the collection of samples and subsequent analysis.
Study Subjects
A consanguineous family of Pakistani origin with two affected
children with BWS due to loss of methylation at KvDMR1 were
investigated in the first instance. Following the identification of
NLRP2 mutations in this family, a further 11 BWS families, each
with a single case of BWS (mean age 10.8 years) with KvDMR1
loss of methylation were analysed for NLRP2 mutations. This
cohort included 10 patients who also had loss of methylation at
other imprinted loci. Ethnically matched laboratory control
samples were analysed to evaluate the significance of novel
sequence variants.
Molecular Genetic Studies
Genomic DNA was extracted from peripheral lymphocytes by
standard techniques.
In preliminary examinations chromosomal abnormalities were
excluded and the methylation status of IC1 and IC2 of imprinting
region 11p15.5 were determined.
Methylation analysis of KvDMR1 was performed as described
previously, with PCR amplification of bisulphite modified DNA
and digestion with restriction enzyme BstU1 yielding different
sized fragments which is separated using ABI377 or 3730 [4]. In
addition, methylation status at 3 additional DMRs was evaluated
at the Transient Neonatal Diabetes Mellitus (TND) locus at 6q24,
7q32 (PEG1) and the Angelman/Prader-Willi locus at 15q13
(SNRPN) as described previously [14]. Primers and methods for the
analysis of the methylation status of PEG1 DMR by methylation
specific PCR (MS-PCR) were obtained from previously published
report by Mackay et al [15].
For linkage studies a genome wide linkage scan was undertaken
using the Affymetrix 250k SNP microarray. Mutation analysis of
JMJD2D, ZFP57, NLRP7 and NLRP2 was carried out by direct
sequencing. The genomic DNA sequence of these genes was taken
from Ensembl (http://www.ensembl.org/index.html) and primer
pairs for the translated exons were designed using primer3 software
(http://fokker.wi.mit.edu/primer3/input.htm). Amplification was
performed according to standard protocols with Bio Mix Red
provided by Bioline. PCR products were directly sequenced by the
Big Dye Terminator Cycle Sequencing System with the use of an
ABI PRISM 3730 DNA Analyzer (Applied Biosystem). DNA
sequences were analyzed using Chromas software.
Results
Case Report
A family with complex consanguinity (Figure 1) was ascertained
after the diagnosis of two children with BWS. Both pregnancies
were complicated by polyhydramnios and raised hHCG levels.
Both affected children were born by Caesarean section. At birth
Child 1 (V-1 in Figure 1) was macrosomic (4.55 kg at 38 weeks
gestation) and was noted to have macroglossia, an omphalocele,
ear creases, right inguinal hernia, undescended testis and neonatal
hypoglycaemia in the first two days after birth. Similarly Child 2
(V-2) was macrosomic (3.633 kg at 35 weeks gestation) with
macroglossia, ear lobe creases and neonatal hypoglycaemia that
was difficult to control. Subsequently a third child was born
without features of BWS (between the second and third children a
probable hydatidiform mole was diagnosed). Molecular studies
demonstrated loss of maternal allele KvDMR1 (IC2) methylation
in both affected children, but the unaffected sibling had normal
methylation. H19 methylation status was normal in both affected
children and MLPA analysis demonstrated no evidence of an IC1
or IC2 deletion. Genotyping revealed no evidence of paternal
uniparental disomy and linkage analysis with microsatellite
markers flanking IC2 (TH and D11S4088) demonstrated that
the two children had inherited opposite maternal and paternal
11p15.5 alleles. These findings were consistent with IC2 epimuta-
tion resulting from a trans imprinting defect.
Molecular Genetic Analysis
In view of the history of consanguinity, an autosomal recessive
disorder was suspected (either affecting both children or affecting
the mother). Genetic linkage studies were undertaken by
genotyping the two children and both parents on an Affymetrix
250k SNP array platform. Five regions of homozygosity
(.2Mbases) were shared by the two children but these did not
contain a gene known to be implicated in the establishment or
maintenance of genomic imprinting. However inspection of the
maternal genotypes revealed an ,8 Mbase homozygous region
Author Summary
A small set of genes (imprinted genes) are expressed in a
‘‘parent-of-origin’’ manner, a phenomenon known as
genomic imprinting. Research in human disorders associ-
ated with aberrant genomic imprinting provided insights
into the molecular mechanisms of genomic imprinting and
the role of imprinted genes in normal growth and
development. Beckwith-Wiedemann syndrome (BWS) is a
congenital overgrowth syndrome associated with devel-
opmental abnormalities and a predisposition to embryonic
tumours. BWS results from alterations in expression or
function of imprinted genes in the imprinted gene cluster
at chromosome 11p15. Although BWS may be caused by a
variety of molecular mechanisms, to date, all the genetic
and epigenetic defects associated with BWS have been
limited to 11p15.5. We report a family with two children
affected with BWS and an epigenetic defect at 11p15.5 in
which the primary genetic defect mapped outside the
imprinted gene cluster. Using autozygosity mapping, we
found an extended homozygous region on chromosome
19q13.4 (containing NLRP2 and NLRP7 genes) in the
mother. Homozygous inactivating mutations in NLRP7 in
women have been associated previously with abnormal
imprinting and recurrent hydatidiform moles. We identi-
fied a homozygous frameshift mutation in NLRP2 in the
mother of the two children with BWS implicating NLRP2 in
the establishment and/or maintenance of genomic im-
printing/methylation.
NLRP2 Mutation and Beckwith-Widemann Syndrome
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containing NLRP2 and NLRP7 at 19q13.4. NLRP7 is a homologue
of the mouse NLRP2 gene (NLRP7 is not present in the mouse) and
the human NLRP2 gene. Sequencing of NLRP2 in the mother
identified a homozygous frameshift mutation ((c.1479delAG,
NM_017852; Figure 2) that was predicted (in the absence of
nonsense-mediated RNA decay) to result in a truncated protein
(p.Arg493SerfsX32) lacking 539 amino acids from the C-terminal
that includes the LRR domain. The mutation was not detected in
542 ethnically matched control chromosomes but the father was
heterozygous for the mutation, child 1 was homozygous for the
mutation and the other two children were heterozygous. Mutation
analysis of 11 additional families with BWS did not reveal any
evidence of pathogenic NLRP2 mutations.
To determine if the trans imprinting defect extended beyond
KvDMR1, we analysed methylation levels at the TND (6q24),
SNRPN (15q13) and PEG1 (7q32) DMRs. Both affected siblings
(and all controls) had normal methylation levels at the TND and
SNRPN DMRs but Child 2 demonstrated partial loss of
methylation at the PEG1 DMR (Figure 3).
Discussion
We identified a homozygous frameshift mutation in the mother
of two children with BWS caused by epimutations at IC2
(KvDMR1). Most cases of BWS due to loss of methylation of
KvDMR1 are sporadic, but a handful of familial cases have been
described with maternally inherited germline IC2 deletions [10].
However, in our family there was no evidence of a germline
deletion by MLPA analysis [16] and the two affected children were
shown to have inherited opposite maternal and paternal 11p15.5
alleles. This suggested that in this family, KvDMR1 LOM resulted
from a trans and not a in cis effect. Germline NLRP2 mutations
have not been reported previously, but mutations in ZFP57 and
NLRP7 can cause imprinting disorders in which epimutations at
imprinted loci result from a trans effect. Thus individuals
homozygous for ZFP57 mutations presented with transient
neonatal diabetes mellitus (TNDM). The major cause of TNDM
is aberrant expression of imprinted genes at chromosome 6q24
and about 20% of cases have LOM at the TND differentially
methylated region (DMR). Patients with homozygous ZFP57
mutations have LOM at the TND DMR, but also at other
imprinted loci including KvDMR1 [15]. However, there was no
evidence of germline ZFP57 mutations in our family. Germline
NLRP7 mutations are associated with familial recurrent biparental
complete hydatidiform mole (FHM) in which there is epigenetic
abnormalities at DMRs in multiple imprinting regions [17–19].
Although FHM associated with NLRP7 mutations is inherited in
an autosomal recessive manner, in contrast to ZFP57 mutation,
homozygotes have normal genomic methylation but in female
homozygotes there is a failure to establish methylation imprints in
their germ cells leading to hydatidiform moles and reproductive
wastage (male homozygotes do not have imprinting defects in their
sperm). The methylation defects in FHM are specific for imprinted
loci, and DNA methylation at non-imprinted genes and genes
subject to X-inactivation is unaffected [18]. The human NLRP2
and NLRP7 genes are highly homologous and the two proteins
consist of 1,062 and 1,009 amino acids respectively and have
identical structure and about 64% amino acid identity. Only one
Figure 1. Family pedigree (partial) to demonstrate complex
consanguinity.
doi:10.1371/journal.pgen.1000423.g001
Figure 2. Germline NLRP2 mutation. The alignments of NLRP2
nucleotides c.1465–c.1492 are shown. (A) is wildtype sequence in a
control, (B) is heterozygous NLRP2 mutation (c.1479delAG) in the father,
and (C) is homozygous 2bp deletion (c.1479delAG) in the mother.
doi:10.1371/journal.pgen.1000423.g002
NLRP2 Mutation and Beckwith-Widemann Syndrome
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of the two affected children with BWS was homozygous for a
NLRP2 mutation and, by analogy with FHM caused by NLRP7
mutations, the BWS phenotype most likely results from homozy-
gosity in the mother, such that familial BWS associated with
NLRP2 mutations is inherited in a similar manner to NLRP7
associated FHM and not in a conventional autosomal recessive
manner.
Both FHM and ZFP57–TNDM are associated with imprinting
aberrations at multiple loci, and we identified partial loss of
methylation at the PEG1 DMR in one of the affected children.
Nevertheless it seems that NLRP2 mutations have a less severe
effect on imprinting than NLRP7 or ZFP57 inactivation. A subset
of children with BWS and an IC2 epimutation display
hypomethylation at multiple imprinting centres (DMRs) (in our
series these children are more likely to have been conceived by
assisted reproductive technologies) [14,20]. To our knowledge,
none of these cases have been familial and we did not identify
NLRP2 mutation in the sporadic cases we studied. It appears that
the establishment (or maintenance) of methylation at KvDMR1 is
particularly sensitive to genetic and/or environmental insults. We
note that one of the affected children demonstrated a partial loss of
methylation at PEG1 DMR1 both by bisulphite sequencing and
MS-PCR suggesting that NLRP2mutations may be associated with
an incomplete failure of imprinting establishment and/or a partial
failure of maintenance methylation at this DMR. Interestingly,
investigation of a mouse knockout of ZFP57 has suggested a role in
both the establishment of germline methylation imprints and in
the postfertilisation maintenance of methylation imprints [21].
NLRP2 and NLRP7 encode members of the NLRP (Nucleotide-
binding oligomerization domain, Leucine rich Repeat and Pyrin
domain) family of CATERPILLER proteins. NLRP family of
cytoplasmic proteins comprises 14 members of similar structure
that are principally encoded by two gene clusters on chromosome
11p15 (NLRP6, 10 and 14) and 19q13.4 (NLRP2, 4, 5, 7, 8, 9, 11,
12 and 13). Most of the family members are well conserved from
C. elegans, D. melanogaster, rat, and mouse to human but there is no
rodent homologue for NLRP7 and the gene is found in only a few
genomes (human, primate and cow). Some NLRP proteins are
components of the inflammasome that is implicated in the sensing
of, and inflammatory reaction to, extracellular pathogens and
intracellular noxious compounds [22]. Germline mutations in
NLRP3 and NLRP12 are associated with familial cold autoin-
flammatory syndrome [23,24]. NLRP2 was suggested to function
as a modulator of macrophage NFKB activation and procaspase 1
[25], however we found that the two family member homozygous
for a NLRP2 truncating mutation did not show any evidence of an
immune or autoinflammatory disorder. Nevertheless most NLRP
family proteins are widely expressed and not restricted to the
immune system. In addition, many are expressed in human
oocytes and embryos at an early stage of development. Thus
Zhang et al. have reported that NLRP4, 5, 8, 9, 11, 12, 13, and 14
were highly expressed in oocytes and then gradually decreased in
embryos with a very low level in day 5 embryos, whilst NLRP2 and
NLRP7 progressively decreased from oocytes to day 3 embryos
then showed a sharp increase on day 5 [26]. These observations
are consistent with NLRP2 and NLRP7 having a similar role in
early development/imprinting establishment. Although it has been
suggested that FHM might result from an immune-related defect
in oogenesis or early embryo development (with methylation
changes being a secondary phenomenon) the specific association of
the methylation defects with imprinted DMRs suggests a more
direct role in the establishment or maintenance of imprinting
marks. Such a view is supported by the identification of germline
NLRP2 mutations in BWS and should prompt further investigation
of the role of NLRP2 and NLRP7 in genomic imprinting. The
apparent involvement of NLRP proteins in genome methylation
and the sensing and inflammatory response to extracellular
pathogens and intracellular noxious compounds is intriguing given
the suggestion that cytosine methylation may have evolved as a
host response to transposons [27]. It is interesting that the third
child in the family we report was unaffected. Most mothers with
NLRP7 mutations have recurrent molar pregnancies only, but at
least three families have been reported in which affected women
had liveborn offspring (see [28] and references within). In one
family, three affected members had, in addition to the molar
phenotype, several miscarriages and three term pregnancies [29].
In one of the term pregnancies the baby was born with severe
intrauterine growth retardation, but grew into a healthy adult with
normal methylation levels [30]. In another term pregnancy the
baby was born with unilateral cleft lip and palate and later
manifested idiopathic delayed mental and motor development
[31]. Murdoch et al. detected a homozygous splice site mutation in
NLRP7 in all three affected women of this family [32]. Thus
homozygous NLRP7 mutations may be associated with clinical
heterogeneity/incomplete penetrance, possibly resulting from
genetic modifier or environmental effects. In the light of these
Figure 3. Loss of methylation at PEG1 DMR. Electropherogram of
amplification products of MS-PCR. U, unmethylated product; M,
methylated product. The X-axis represents the calculated product size
(in bp and also represented as the top number in the box). The Y axis
represents the peak height (bottom number in the box). The
methylated to unmethylated ratio was calculated as the area under
the curve (middle number in the box) of methylated versus
unmethylated amplified products. (A) Normal Control (ratio 0.81), (B)
Child 2 with LOM at PEG1.
doi:10.1371/journal.pgen.1000423.g003
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observations and the apparently milder phenotypic effects of
maternal NLRP2 inactivation than NLRP7 inactivation (Beckwith-
Wiedemann syndrome and molar pregnancy respectively) it might
be predicted that clinical heterogeneity/incomplete penetrance
would be a feature of maternal NLRP2 inactivation. Although
maternal NLRP2 mutations appear to be a rare cause of familial
BWS, the identification of these cases is important, as the
inheritance pattern differs from the autosomal dominant inheri-
tance (with parent of origin effects) associated with other inherited
forms of BWS. The inheritance of NLRP2-associated BWS has
similarities to other autosomal recessive disorders in which
homozygous mothers are well, but there is a high risk to their
offspring (e.g. FHM and treated maternal phenylketonuria).
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